×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NASDAQ:NYMX

Nymox Pharmaceutical News Headlines

$0.45
0.00 (0.00%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.43
$0.49
50-Day Range
$0.38
$1.41
52-Week Range
$0.35
$2.27
Volume
157,623 shs
Average Volume
208,241 shs
Market Capitalization
$40.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Nymox Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter.

NYMX Media Mentions By Week

NYMX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NYMX
News Sentiment

0.00

0.39

Average
Medical
News Sentiment

NYMX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NYMX Articles
This Week

1

0

NYMX Articles
Average Week



NYMX Stock News Headlines Today

SourceHeadline
MarketBeat logoNymox Pharmaceutical (NASDAQ:NYMX) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - June 23 at 3:55 AM
marketwatch.com logoNymox Pharmaceutical Down 64% on FDA Refusal to File Letter
marketwatch.com - May 23 at 11:44 PM
seekingalpha.com logoNYMOX down 46% on Refuse to File letter from FDA for fexapotide for enlarged prostate
seekingalpha.com - May 23 at 6:43 PM
marketwatch.com logoNymox Application for Fexapotide Triflutate Rejected by FDA >NYMX
marketwatch.com - May 23 at 6:43 PM
benzinga.com logoWhy Nymox Pharma Shares Sinking to 52-Week Low?
benzinga.com - May 23 at 10:19 AM
uk.investing.com logoExecutives Buy Around $5M Of 4 Penny Stocks
uk.investing.com - May 9 at 1:45 PM
nasdaq.com logoFriday 5/6 Insider Buying Report: ALGN, NYMX
nasdaq.com - May 6 at 12:42 PM
finance.yahoo.com logoNymox Announces Closing of $6.4 Million Financing
finance.yahoo.com - April 4 at 7:11 PM
finance.yahoo.com logoA Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider increased their holdings by 1.1% last year
finance.yahoo.com - April 3 at 5:41 PM
msn.com logoHere's Why Nymox Pharmaceuticals Shares Are Moving
msn.com - March 18 at 3:30 PM
baystreet.ca logoNymox Direct Offering
baystreet.ca - March 18 at 10:29 AM
seekingalpha.com logoNymox Pharmaceutical announces $5M registered direct offering
seekingalpha.com - March 18 at 10:29 AM
finance.yahoo.com logoNymox Announces $5 Million Registered Direct Offering
finance.yahoo.com - March 18 at 10:29 AM
marketwatch.com logoNymox Seeks FDA OK for Enlarged Prostate Treatment >NYMX
marketwatch.com - March 3 at 5:06 PM
seekingalpha.com logoNymox stock rises 8% as it files for FDA approval of drug treating enlarged prostate
seekingalpha.com - March 3 at 5:06 PM
finance.yahoo.com logoNYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate
finance.yahoo.com - March 3 at 5:06 PM
nasdaq.com logoInsiders at Nymox Pharmaceutical Corporation (NASDAQ:NYMX) recouped some losses this week after buying this year, still down US$31k
nasdaq.com - January 3 at 2:38 PM
nasdaq.com logoNymox Pharmaceutical Corp Shares Near 52-Week Low - Market Mover
nasdaq.com - December 31 at 12:22 PM
finance.yahoo.com logoNymox Shareholder Update
finance.yahoo.com - December 13 at 1:26 PM
finance.yahoo.com logoNYMOX Presenting at Torrey Hills Capital Emerging Growth Conference
finance.yahoo.com - November 15 at 3:10 PM
finance.yahoo.com logoNYMOX Provides Current Update
finance.yahoo.com - October 11 at 3:54 PM
au.finance.yahoo.com logoLennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent Family
au.finance.yahoo.com - September 11 at 11:19 PM
finance.yahoo.com logoNYMOX Provides Shareholder Update
finance.yahoo.com - September 10 at 9:45 AM
nasdaq.com logoNymox Pharmaceutical Corporation Common Stock (Bahamas) (NYMX)
nasdaq.com - August 2 at 7:34 PM
finance.yahoo.com logoWho Has Been Buying Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Shares?
finance.yahoo.com - July 27 at 2:17 PM
finance.yahoo.com logoNymox Announces Date for Fexapotide Filing
finance.yahoo.com - May 6 at 1:56 PM
ca.finance.yahoo.com logoDo Insiders Own Lots Of Shares In Nymox Pharmaceutical Corporation (NASDAQ:NYMX)?
ca.finance.yahoo.com - April 30 at 10:48 PM
finance.yahoo.com logoNymox Announces $8,000,000 Private Placement
finance.yahoo.com - April 28 at 12:44 PM
finance.yahoo.com logoNymox Provides New Update on Regulatory Activities
finance.yahoo.com - March 29 at 12:22 PM
markets.businessinsider.com logoNymox Provides Update on Regulatory Filing Activities
markets.businessinsider.com - November 16 at 10:33 AM
finance.yahoo.com logoWhat You Need To Know About Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) Investor Composition
finance.yahoo.com - November 3 at 10:03 AM
ca.finance.yahoo.com logoNYMX Nov 2020 7.000 call
ca.finance.yahoo.com - August 20 at 12:22 PM
finance.yahoo.com logoNymox Announces $9 Million Registered Direct Offering
finance.yahoo.com - August 12 at 11:17 AM
ca.finance.yahoo.com logoNymox Pharmaceutical Corp. Regi (NYM.SG)
ca.finance.yahoo.com - July 30 at 5:55 PM
finance.yahoo.com logoNYMOX Provides Current Update on Key Company Developments
finance.yahoo.com - July 28 at 9:46 AM
seekingalpha.com logoNymox (+8%) on track to file fexapotide applications in ~four months
seekingalpha.com - June 19 at 2:51 PM
finance.yahoo.com logoNymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
finance.yahoo.com - June 19 at 9:46 AM
uk.finance.yahoo.com logoKeep an eye on the price momentum at Nymox Pharmaceutical
uk.finance.yahoo.com - June 16 at 8:43 AM
finance.yahoo.com logoHedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)
finance.yahoo.com - June 5 at 5:51 PM
finance.yahoo.com logoIf You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
finance.yahoo.com - May 5 at 9:39 AM
finance.yahoo.com logoIf You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
finance.yahoo.com - May 5 at 9:39 AM
www.bloomberg.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nymox Pharmaceutical Corporation (NYMX)
www.bloomberg.com - April 25 at 10:36 PM
finance.yahoo.com logoNymox Announces Important New Patent Developments
finance.yahoo.com - April 21 at 11:08 AM
finance.yahoo.com logoIs Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - March 21 at 10:42 AM
finance.yahoo.com logoNymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
finance.yahoo.com - February 24 at 9:35 AM
seekingalpha.com logoNymox Pharmaceutical: Employee Resume Substantiates Concerns
seekingalpha.com - February 20 at 3:04 PM
seekingalpha.com logoNymox Pharmaceuticals Has A Long History Of Broken Promises And Baffling Delays That Will Likely Continue
seekingalpha.com - February 6 at 12:39 PM
finance.yahoo.com logoNymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
finance.yahoo.com - February 6 at 12:39 PM
finance.yahoo.com logoIs Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
finance.yahoo.com - February 5 at 7:31 PM
finance.yahoo.com logoIs Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
finance.yahoo.com - February 5 at 2:31 PM
Get Nymox Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:NYMX) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.